Recent Finacing
Recent Raise
Heptares operates a structure-based drug design platform to develop GPCR-targeting small-molecule therapeutics, advancing a pipeline for Alzheimer's, Parkinson's, schizophrenia, migraine, and diabetes and collaborating with pharmaceutical partners.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
